ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
S&P ASX 200
7,597.50
0.36%
S&P ASX All Technology
2,979.70
0.37%
Brent Oil
83.96
0.50%
US Dollar vs AUD
1.52975
-0.08%
Bitcoin
57,393.14
-1.45%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. ESSA Pharma Inc (EPIX)

  7. ESSA Pharma Inc (EPIX) News

EPIX

ESSA Pharma (EPIX)

ESSA Pharma Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:EPIX
DateTimeSourceHeadlineSymbolCompany
09/04/202422:00PR Newswire (Canada)ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor ConferenceNASDAQ:EPIXESSA Pharma Inc
09/04/202422:00PR Newswire (US)ESSA Pharma to Present at the 2024 Bloom Burton & Co. Healthcare Investor ConferenceNASDAQ:EPIXESSA Pharma Inc
08/03/202412:13PR Newswire (US)ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERSNASDAQ:EPIXESSA Pharma Inc
08/03/202412:13PR Newswire (Canada)ESSA PHARMA INC. REPORTS RESULTS OF ANNUAL GENERAL MEETING OF SHAREHOLDERSNASDAQ:EPIXESSA Pharma Inc
08/03/202409:18Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EPIXESSA Pharma Inc
06/03/202410:50Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EPIXESSA Pharma Inc
13/02/202423:01Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:EPIXESSA Pharma Inc
13/02/202423:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EPIXESSA Pharma Inc
13/02/202423:00PR Newswire (US)ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2023NASDAQ:EPIXESSA Pharma Inc
13/02/202423:00PR Newswire (Canada)ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal First Quarter Ended December 31, 2023NASDAQ:EPIXESSA Pharma Inc
08/02/202403:29Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EPIXESSA Pharma Inc
07/02/202400:27Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EPIXESSA Pharma Inc
07/02/202400:00PR Newswire (US)ESSA Pharma to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:EPIXESSA Pharma Inc
07/02/202400:00PR Newswire (Canada)ESSA Pharma to Present at the Oppenheimer 34th Annual Healthcare Life Sciences ConferenceNASDAQ:EPIXESSA Pharma Inc
30/01/202401:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EPIXESSA Pharma Inc
27/01/202408:40Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:EPIXESSA Pharma Inc
27/01/202408:27Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:EPIXESSA Pharma Inc
26/01/202402:00PR Newswire (US)ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 2024 ASCO Genitourinary Cancers SymposiumNASDAQ:EPIXESSA Pharma Inc
26/01/202402:00PR Newswire (Canada)ESSA Pharma Presents Updated Phase 1 Masofaniten (EPI-7386) Clinical Data at the 2024 ASCO Genitourinary Cancers SymposiumNASDAQ:EPIXESSA Pharma Inc
24/01/202408:09Edgar (US Regulatory)Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]NASDAQ:EPIXESSA Pharma Inc
18/01/202412:57Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EPIXESSA Pharma Inc
17/01/202408:19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EPIXESSA Pharma Inc
17/01/202405:41Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EPIXESSA Pharma Inc
09/01/202412:06Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EPIXESSA Pharma Inc
06/01/202408:04Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNASDAQ:EPIXESSA Pharma Inc
12/12/202323:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:EPIXESSA Pharma Inc
12/12/202323:00Edgar (US Regulatory)Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]NASDAQ:EPIXESSA Pharma Inc
12/12/202323:00PR Newswire (US)ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2023NASDAQ:EPIXESSA Pharma Inc
12/12/202323:00PR Newswire (Canada)ESSA Pharma Provides Corporate Update and Reports Financial Results for Fiscal Fourth Quarter and Year Ended September 30, 2023NASDAQ:EPIXESSA Pharma Inc
25/11/202303:11Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:EPIXESSA Pharma Inc
 Showing the most relevant articles for your search:NASDAQ:EPIX

Your Recent History

ASX
BHP
BHP
ASX
WDC
Westfield
CCOM
SILVER
SILVER
FX
EURAUD
Euro vs AUD
FX
GBPAUD
Sterling vs AUD
FTSE
UKX
FTSE 100
PM
XAUUSD
Gold vs US Dollar
FX
AUDCAD
AUD vs CAD
ASX
XAO
Australian SE All Ordina...
ASX
CSL
CSL
COIN
BTCUSD
Bitcoin
ASX
RIO
Rio Tinto
FX
AUDJPY
AUD vs Yen
NYSE
KO
Coca Cola
NASDAQ
TSLA
Tesla
Delayed Upgrade Clock
ADVFN Logo

Australia
Company
Business
Popular
Get The App

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved